Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

BACKGROUND: Dabigatran is a novel oral anticoagulant approved for thromboprophylaxis in atrial fibrillation. Adoption patterns of this new agent in community practice are unknown. METHODS AND RESULTS: We studied patterns of dabigatran use among patients enrolled in the Outcomes Registry for Better I...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Steinberg, Benjamin A., Holmes, DaJuanicia N., Piccini, Jonathan P., Ansell, Jack, Chang, Paul, Fonarow, Gregg C., Gersh, Bernard, Mahaffey, Kenneth W., Kowey, Peter R., Ezekowitz, Michael D., Singer, Daniel E., Thomas, Laine, Peterson, Eric D., Hylek, Elaine M.
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2013
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3886732/
https://ncbi.nlm.nih.gov/pubmed/24275632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000535
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker